外科手术目前仍是治疗局限的非小细胞肺癌的首选方法[1] 。手术不仅会程度不一地影响肺功能 ,还对心脏功能造成较大影响。加之肺癌患者多是吸烟者或曾经吸烟 ,同时伴有不同程度的慢性阻塞性肺疾病和 /或缺血性心脏病 ,这使术后发生心肺并发症的危险性大大增加。因此 ,对肺癌患? Surgery is still the preferred method for treating locally-restricted NSCLC [1]. Surgery not only affects the lung function in varying degrees, but also has a major impact on cardiac function. In addition, lung cancer patients are mostly smokers or have smoked, accompanied by different degrees of chronic obstructive pulmonary disease and / or ischemic heart disease, which greatly increases the risk of post-operative cardiopulmonary complications. So, what about lung cancer?